# Effect of Vitamin D3 on Transected and Crushed Injuries in Rat Sciatic Nerve Healing

**Authors:** Inanc Dogan Cicek, Handan Derebasinlioglu, Ayse Demirkazik, Hatice Reyhan Egilmez

PMC · DOI: 10.3390/biomedicines14020481 · Biomedicines · 2026-02-22

## TL;DR

This study examines how vitamin D3 affects the healing of two types of nerve injuries in rats, finding mixed results depending on the injury type.

## Contribution

The study provides new insights into the differential effects of vitamin D3 on transected versus crushed nerve injuries in rats.

## Key findings

- Vitamin D3 improved myelination in transected nerves but had no significant overall benefit.
- Vitamin D3 negatively impacted the healing of crushed nerves based on electrophysiological and histopathological results.
- The efficacy of vitamin D3 treatment varied depending on the type of nerve injury.

## Abstract

Background: Peripheral nerve injury can happen for a variety of causes. Despite major breakthroughs in microsurgery, nerve repair results are not always sufficient. Methods: Thirty-two Wistar albino rats were split into four groups: primary nerve repair (PNR), PNR with vitamin D3 treatment, nerve crush injury (NCI), and NCI with vitamin D3 treatment. In the PNR + D3 and NCI + D3 groups, 1 mcg/kg of vitamin D3 was given intraperitoneally on days 1, 3, 5, and 7 of the 12-week healing period. Electrophysiological measurements were taken prior to the injury. At 12 weeks after damage, a hot plate test was performed to assess acute pain, and the electrophysiological measurements were repeated. Before the rats were sacrificed, biopsy samples from the right sciatic nerve were collected for histopathological evaluation. Results: Post-healing action potential values were not statistically different between the PNR and PNR + D3 groups; however, they were considerably lower in the NCI + D3 group than in the NCI group. The reaction time in the hot plate test was considerably slower in the D3-treated groups compared to the control groups. Histopathology score was substantially higher in the PNR + D3 group as compared to the PNR group, and lower in the NCI + D3 group as compared to the NCI group. Conclusions: Other than improved myelination, vitamin D3 treatment following primary repair of transected nerves produced no statistically significant improvement. Vitamin D3 treatment caused a negative impact on the crush injury, as assessed by the findings of histopathology and electrophysiological measurements. Overall, the results indicate that the efficacy of vitamin D3 treatment may vary depending on the type of injury.

## Linked entities

- **Chemicals:** vitamin D3 (PubChem CID 5280795)

## Full-text entities

- **Genes:** Ngfr (nerve growth factor receptor) [NCBI Gene 24596] {aka LNGFR, RNNGFRR, Tnfrsf16, p75, p75NTR}
- **Diseases:** transection injuries (MESH:D061220), PNR (MESH:D049914), demyelination (MESH:D003711), nervous system traumas (MESH:D020196), crush injury (MESH:D000071576), nerve injuries (MESH:D000080902), brain damage (MESH:D001925), amyotrophic lateral sclerosis (MESH:D000690), cognitive decline (MESH:D003072), axonal injury (MESH:D001480), chronic (MESH:D002908), multiple sclerosis (MESH:D009103), cold allodynia (MESH:D006930), Damages to the peripheral nerves (MESH:D010523), neuronal degeneration (MESH:D009410), sciatic nerve crush damage (MESH:D020426), chronic pain (MESH:D059350), Alzheimer's disease (MESH:D000544), diabetes mellitus (MESH:D003920), pain (MESH:D010146), Peripheral nerve injury (MESH:D059348), nodulation (MESH:D016606), facial nerve injury (MESH:D020220), Parkinson's disease (MESH:D010300), nerve transection (MESH:D020221), Injuries (MESH:D014947), neurodegenerative diseases (MESH:D019636), inflammatory (MESH:D007249), metabolic syndrome (MESH:D024821), neuromas (MESH:D009463), low back pain (MESH:D017116), acute pain (MESH:D059787), nerve (MESH:C537568), Hypovitaminosis D (MESH:D014808)
- **Chemicals:** vitamin D2 (MESH:D004872), + D3 (MESH:D002762), K (MESH:D011188), Na+ (MESH:D012964), hematoxylin (MESH:D006416), H2O2 (MESH:D006861), DeltaPP (-), formaldehyde (MESH:D005557), polypropylene (MESH:D011126), xylene (MESH:D014992), xylazine (MESH:D014991), platinum (MESH:D010984), paraffin (MESH:D010232), vitamin D (MESH:D014807)
- **Species:** Homo sapiens (human, species) [taxon 9606], Rattus norvegicus (brown rat, species) [taxon 10116], Oryctolagus cuniculus (domestic rabbit, species) [taxon 9986], Mus musculus (house mouse, species) [taxon 10090]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12938785/full.md

## Figures

4 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12938785/full.md

## References

42 references — full list in the complete paper: https://tomesphere.com/paper/PMC12938785/full.md

---
Source: https://tomesphere.com/paper/PMC12938785